“Immunogenicity of Guselkumab (GUS) Among Psoriasis Patients in VOYAGE (VOY) 1&2 Studies”. SKIN The Journal of Cutaneous Medicine 6, no. 2 (March 4, 2022): s11. Accessed May 22, 2026. https://skin.dermsquared.com/skin/article/view/1528.